Report Keyword:

Chinese Medicine Injection Industry Prospects and Investment Forecast Report, 2013-2017

Chinese Medicine Injection Industry Prospects and Investment Forecast Report, 2013-2017

Last Update:2014-06-02

Form of services:Book + (pdf or doc file) + CD

Send method:EMS 2-3 days for delivery

English Service:+86 0755 33220413

Chinese Service:+86 800-8306390 800-8306395

E-mail:service.en@qianzhan.com

Report price:$7900   Print: $7800   CD: $7800

Online Consultation
Special statement:
Recently we find there are some sites steal report contents from Qianzhan.com who put those contents on their sites for sale by making a little changes about the contents or remaining the same which deceives buyers(e.g. unable to get full or correct reports, or main body differs from contents that announced on sites).Therefore, we recommend paying a visit to Qianzhan personally or by your friends, and make payment after confirmation. Special statement: Qianzhan is the only and right holder of all the research reports, and has never used a third party to sell any reports, please be aware of the trademark " " when purchasing. Qianzhan is the largest and strongest consultancy, who owns the greatest number of researchers. Here followed "Nine standards of companies' identificatios"。

This table of content is original, without written permission of Qianzhan, any unit or individual shall not use, copy, or transfer the reports.

Preface

Table of Content

Chinese medicine injection is a product of Chinese medicine modernization. Basing on the accurate healing effect of traditional Chinese medicine, it changes the traditional drug delivery and fastens the healing effect as well as widens the serviceable range of Chinese medicine. The Chinese medicine injection has been widely used in clinical cases especially in the fields of cardiovascular and cerebrovascular diseases treatment and serious respiratory system diseases. It is with an irreplaceable advantage which the chemicals do not possess.

Comparing with traditional Chinese medicine, Chinese medicine injection is an innovation new medicine. The whole industry is on the babyhood but it develops fast that it takes the biggest market share in the field of Chinese medicine. The annual growth rate of Chinese medicine injection market is over 30% from 1999 to 2006. There is a stop and industry reorganization in 2006 due to the Chinese medicine injection “houttuynia cordata event”. Since then the industry develops in a stable and low-speed way. Currently, market scale of Chinese medicine injection has exceeded 30 billion Yuan.

There are 141 Chinese medicine injections by May 21st, 2011 (statistic according to approval product names, for changing formulations varieties it is calculated by different categories). In current years, the growth rate of various Chinese medicine injections has exceeded the average level of Chinese medicine industry (the average level is about 20%). And there are many products with a compound growth rate of over 30%.

According to data from the Southern Medicine Economic Institute, among the ready-made medicine in 9 major cities in 2010, injection medicament form takes a biggest proportion of about 35% and exceeds traditional medicament forms such as capsule and troche. The Chinese medicine injection is widely used in 5 major diseases and gains a good healing effect. The 5 major diseases are cardiovascular and cerebrovascular diseases, respiratory system diseases, neoplastic diseases, musculoskeletal system diseases and digestive diseases. The cardiovascular and cerebrovascular diseases take the biggest proportion which is about 59%.

Due to the frequent safety issues, SFDA stopped the examination of Chinese medicine injection since 2008, and started the evaluation of the products which ware selling in the market since 2009. Until the Tasly injection Danshen Phenolic Acids got a new drug certificate which is approved by the State Food and Drug Administration in April, 2011, that the situation began to change a bit. This event means that the examination and approval of Chinese medicine injection is available again. The loosening policies will bring fast development and new opportunities for the industry.

In spite of the policies advantages, corporations gradually pick up confidence of Chinese medicine injection. Kunmin Pharmaceutical CO., Ltd. proposed an additional issue scheme on October 15th, 2011 that would issue no more than 68 million stocks which may raises funds of 700 million Yuan, and would invest 4 projects which may cost 928 million Yuan. The raising fund will be used to improve the production capacity of internationalization pharmaceutics, small volume injection production line and subsidiary company, the Kunmin Chinese Medicine Factory, as well as technical center innovation capability construction. The additional project of Kunmin Pharmaceutical CO., Ltd. is promising.

Major characteristics of this report are forward-looking and timeliness. Base on the forward-looking analysis of massive research data, we further analyze the development scale and competitive landscape of Chinese medicine injection industry. Along with the industry development route and our practical experience, we analyze and predict the future development prospect of Chinese medicine injection industry. This report contains a high value for both industry manufacturers and investment corporations that they can accurately know the latest industry development trend, obtain market opportunities and determine an insightful operation strategy and development direction. In the meantime, it is the first heavy weight report to analyze the up/down-stream industry chain and industry leading corporations of Chinese medicine injection industry in an overall and systemic way.

Here, we’d like to express our sincere gratitude to Southern Medicine Economic Institute, National Statistics Bureau of China, International Information Institute, National Institute of the Ministry of Commerce, National Tsing Hua University Library, Institute of Market Economy of the State Council Development Research Center, and Beijing Qinghua Forward Market Research Center, etc. Thank you so much!

 

Qianzhan Business Information Co., Ltd. Industry Research College
Research Team of Chinese Medicine Injection


Chinese Medicine Injection Industry Report" related reports »

Purchase Mode:

1. English Service:  +86 0755 33220413

2. Chinese Service:  +86 8008306390 8008306395

3. Mail Order:  service.en@qianzhan.com

4. Online Order:  Click "Order Now" button on this page

5. Purchase On-site:  19F Block A, First World Plaza, Hongli West Rd, Futian District, Shenzhen China

Warm tips:
  • 1. Please be aware of " Qianzhan " trademark, qianzhan has never used any third to sell reports, please make a phone call and purchase it directly.
  • 2. You are warmly welcome to visit Qianzhan, and close transaction after confirmation.
Industry Research
·Energy and Environment»
New Energy Natural Gas Energy Conservation Water Resources Coal Electricity Others
·Recreation and Sports»
Education Advertisement Film and Television Publication Packing and Printing Sports Resort Hotel Catering Internet Animation Others Media
·Financial Services»
Banking Insurance Securities Leasing Credit Others
·Transport Logistics and Supporting»
Water Transport Airport Road Transport Logistic Distribution Vehicle and Fittings Post-Market Others
·Medical and Health»
Medical Device Biomedicine Medical Institution Healthcare and Nursing Medicine and Pharmacy Others
·Retail or FMCG»
Retail Commercial Trade Food Beverage Dairy Product Seasoning Wine and Tobacco Cosmetics Cleaning Product Daily Necessities Others
·Real Estate and Construction»
Real Estate Real Estate Intermediary Public Safety Construction Engineering Survey and Design Building Materials Housing Accomodation Others
·Mechanical Manufacturing»
Precision Instrument Transport Instrument Electricity Supporting Equipment Special Equipment General Equipment Others
·New Chemical Material»
Ink and Pigment Coating Chemical Fibres Synthetic Fibres Chemicals Industrial Chemicals Rubber Plastics Basic Chemicals Others
·Light Textile and Clothing»
Luxury Jewelry Leather Raw Materials Shoes and Hats Clothing Textile Others
·Household Appliance and IT»
White Goods Optic Instrument Electrical Component Semiconductor Brown Goods Small Appliances Communication IT Consumer Electronics Others
·Minerals and Metallurgy»
Metal Product Metallurgy Non-Ferrous Metal Steel Mining Industry Others
Copyright Notice

1. The copyright of this report is reserved by Qianzhan Business Information Co., Ltd. (Industry Research Institute of Qianzhan), the shipment and post-sale service is handled by the issue department of Qianzhan Business Information Co., Ltd. (Industry Research Institute of Qianzhan). The only copyright of all research report products of our company is reserved; we did not authorize any third party sales agent, if you are to purchase our report, please contact our customer service directly.

2. A limited of customers are offered with our reports with compensation; those reports are only for internal usage and are only for researching and analyzing purposes. We will not be responsible for any misunderstanding or legal issues caused by external usage or references with the report.

More>>
Beginner's Guide
Order Reference
Delivery & Payment
Sale protection
Service Hotline
  • Order Hotline:+86 800-830-6390
  • Customer service:
    +86 800-830-6395
    +86 400-068-7188